Gaukhar Nukenova
Biographic Data
| ID | 10023686 |
|---|---|
| NAME | Gaukhar Nukenova |
| GIVEN NAMES | Gaukhar |
| FAMILY NAME | Nukenova |
| SIGNATURE | NUKENOVA G |
| AFFILIATIONS | National Research Center for Maternal and Child Health |
| ORCID | 0000-0002-6661-0392 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Barriers to vaccine acceptance and immunization coverage in Kazakhstan
Background: Vaccine hesitancy remains a significant public health challenge, affecting immunization coverage and increasing the risk of vaccine-preventable diseases. Understanding the factors influencing vaccine acceptance is crucial for developing targeted interventions. This study examines immunization coverage, vaccine hesitancy, and barriers to vaccine uptake in Kazakhstan, focusing on routine childhood immunization, COVID-19 vaccination, and…
Effectiveness of four vaccines in preventing Sars-CoV-2 infection in Almaty, Kazakhstan in 2021
Background In February 2021 Kazakhstan began offering COVID-19 vaccines to adults. Breakthrough SARS-CoV-2 infections raised concerns about real-world vaccine effectiveness. We aimed to evaluate effectiveness of four vaccines against SARS-CoV-2 infection. Methods We conducted a retrospective cohort analysis among adults in Almaty using aggregated vaccination data and individual-level breakthrough COVID-19 cases (≥14 days from 2nd dose) using nati…
No prominent works on this page.
Effectiveness of four vaccines in preventing Sars-CoV-2 infection in Almaty, Kazakhstan in 2021
Background In February 2021 Kazakhstan began offering COVID-19 vaccines to adults. Breakthrough SARS-CoV-2 infections raised concerns about real-world vaccine effectiveness. We aimed to evaluate effectiveness of four vaccines against SARS-CoV-2 infection. Methods We conducted a retrospective cohort analysis among adults in Almaty using aggregated vaccination data and individual-level breakthrough COVID-19 cases (≥14 days from 2nd dose) using nati…
Barriers to vaccine acceptance and immunization coverage in Kazakhstan
Background: Vaccine hesitancy remains a significant public health challenge, affecting immunization coverage and increasing the risk of vaccine-preventable diseases. Understanding the factors influencing vaccine acceptance is crucial for developing targeted interventions. This study examines immunization coverage, vaccine hesitancy, and barriers to vaccine uptake in Kazakhstan, focusing on routine childhood immunization, COVID-19 vaccination, and…
Environmental health (2 works) · Medicine (2 works) · SARS-CoV-2 and COVID-19 Research (2 works) · Vaccine Coverage and Hesitancy (2 works) · Antibody (1 work) · Cervical Cancer and HPV Research (1 work) · Cohort (1 work) · Cohort study (1 work) · Computer Science (1 work) · Confidence interval (1 work)